New Weight-Loss drug HS235 begins first human tests
Disease control
Completed
This early-phase trial tested HS235, an experimental drug, in 39 overweight or obese but otherwise healthy adults. The main goal was to check safety and how the drug behaves in the body, not to measure weight loss. Participants received either HS235 or a placebo as a shot under t…
Phase: PHASE1 • Sponsor: 35Pharma Inc • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC